TABLE 3

Dose Received by Technologists Using Different Methods to Shield Injection Dose

Shielding typenMean dose ± SD
μSv/procedurenSv/MBq
None93.4 ± 1.79.7 ± 2.3
Primary93.6 ± 1.58.6 ± 2.9
Primary and secondary691.9 ± 0.94.5 ± 2.2
  • Dose includes period of dose transport and injection. Primary and secondary shielding refers to total of 32.7 mm of lead-equivalent shielding.